Brooke Hinkson
Corporate Officer/Principal chez MERCK & CO., INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Robert Davis | M | 57 | 10 ans | |
Chris Decker | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
David R. Bobbitt | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 7 ans |
Stephen Mayo | M | 62 | 3 ans | |
Dalton Smart | M | 58 | 15 ans | |
Pamela Craig | F | 67 | 9 ans | |
Jennifer Zachary | F | 46 | 6 ans | |
Chirfi Guindo | M | 58 | 13 ans | |
Mary Coe | F | 57 | 5 ans | |
Christine Seidman | M | 71 | 4 ans | |
Kathy Warden | F | 52 | 4 ans | |
Tom Glocer | M | 63 | 17 ans | |
Caroline Litchfield | F | 55 | 34 ans | |
Paul Rothman | M | 65 | 9 ans | |
Inge Thulin | M | 69 | 6 ans | |
Patricia Russo | F | 71 | 29 ans | |
Risa Lavizzo-Mourey | M | 69 | 4 ans | |
Douglas Baker | M | 65 | 2 ans | |
Damini Chokshi | F | - | - | |
Kelly E. W. Grez | F | - | - | |
Jannie Oosthuizen | M | - | 3 ans | |
Steven Graziano | M | - | 18 ans | |
Joyce Sensmeier | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Lisa Lin | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 2 ans |
Johanna Herrmann | F | - | - | |
Sylvia A. Ayler | F | - | 3 ans | |
Karen Curran | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 2 ans |
Andre Musto | M | - | 10 ans | |
Julie Cunningham | F | - | - | |
Christina Reith | F | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Carol Bowden | F | - | 10 ans | |
Allan Gabor | M | - | 11 ans | |
Michael Klobuchar | M | 48 | 3 ans | |
David Hardison | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Sanat Chattopadhyay | M | - | 15 ans | |
Fiona Hamilton Marshall | M | 59 | - | |
Anand Ganesan | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
James Matteucci | M | - | 21 ans | |
Richard DeLuca | M | 61 | 13 ans | |
Dean Li | M | 62 | 7 ans | |
Douglas J. Peddicord | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Pamela Eisele | F | - | 15 ans | |
Dominic F. Labriola | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 1 ans |
Denise Williams | F | - | 15 ans | |
Cristal Downing | M | 55 | 3 ans | |
Peter Dannenbaum | M | - | 7 ans | |
Isabelle de Zegher | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Dave Williams | M | 55 | 4 ans | |
Joseph Romanelli | M | 50 | 2 ans | |
Eric Rubin | M | 65 | 6 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kenneth Frazier | M | 69 | 30 ans | |
Rochelle Lazarus | F | 76 | 16 ans | |
Teri Loxam | F | 52 | 4 ans | |
Natarajan Sethuraman | M | 62 | 10 ans | |
John Noseworthy | M | 71 | - | |
Michael Nally | M | 48 | 10 ans | |
David A. Evans | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 3 ans |
Craig Thompson | M | 71 | 10 ans | |
Peter Wendell | M | 73 | 21 ans | |
Wendell Weeks | M | 64 | 16 ans | |
Leslie Brun | M | 72 | 13 ans | |
Sheila Ranganath | F | - | 5 ans | |
Charles Kidder | M | 79 | 12 ans | |
Quentin Roach | M | 57 | 4 ans | |
Kevin Ali | M | 63 | 2 ans | |
Daniel Pascheles | M | - | 11 ans | |
John Markels | M | 58 | - | |
Christopher Galloway | M | 53 | 2 ans | |
Marvin Johnson | M | 61 | 2 ans | |
Lisa LeCointe-Cephas | F | 42 | 6 ans | |
Aaron Falcione | M | 53 | - | |
Soren Christiansen | M | 68 | 19 ans | |
Joseph Arena | M | 69 | 1 ans | |
Arnaub Chatterjee | M | - | 5 ans | |
Vicki Goodman | M | 55 | 1 ans | |
Guy Padbury | M | - | 6 ans | |
Jared Cumming | M | - | 1 ans | |
Amy Klug | F | - | - | |
Rongqiang Liu | M | 58 | 4 ans | |
Tracy Ogden | F | - | - | |
Sandy Tremps | F | - | 33 ans | |
Clark Golestani | M | 57 | 24 ans | |
Willie Deese | M | 68 | 12 ans | |
Adam Schechter | M | 59 | 30 ans | |
Michael Rosenblatt | M | 76 | 32 ans | |
Tamara Elias | M | 53 | 2 ans | |
Michael Holston | M | 61 | 6 ans | |
Mathai Mammen | M | 57 | 1 ans | |
Joe Pedersen | M | - | 23 ans | |
Sandra Milligan | M | 60 | 5 ans | |
Ken Johnson | M | 61 | 1 ans | |
Franklin Clyburn | M | 59 | 13 ans | |
Phillip Samayoa | M | 37 | - | |
Andrew Davis | M | 38 | 1 ans | |
James Scholefield | M | 62 | 1 ans | |
Guy Patrick M. Eiferman | M | - | 4 ans | |
Francesco Maria Lavino | M | 51 | 2 ans | |
Steven Mizell | M | 64 | 8 ans | |
Roger Dansey | M | 67 | 3 ans | |
Jonathan Robbins | M | - | 6 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Brooke Hinkson
- Réseau Personnel